KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 130 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $84,000 | -9.7% | 24,691 | 0.0% | 0.00% | – |
| Q2 2018 | $93,000 | -21.8% | 24,691 | -15.0% | 0.00% | – |
| Q1 2018 | $119,000 | -7.0% | 29,039 | +5.4% | 0.00% | -100.0% |
| Q4 2017 | $128,000 | -50.6% | 27,539 | -24.6% | 0.00% | 0.0% |
| Q3 2017 | $259,000 | -2.6% | 36,539 | -0.5% | 0.00% | 0.0% |
| Q2 2017 | $266,000 | +17.7% | 36,739 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $226,000 | +5.1% | 36,739 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $215,000 | +10.3% | 36,739 | -0.1% | 0.00% | 0.0% |
| Q3 2016 | $195,000 | -4.4% | 36,789 | +19.5% | 0.00% | 0.0% |
| Q2 2016 | $204,000 | +20.0% | 30,789 | -15.3% | 0.00% | 0.0% |
| Q1 2016 | $170,000 | +9.7% | 36,339 | +18.6% | 0.00% | 0.0% |
| Q4 2015 | $155,000 | +269.0% | 30,649 | +154.8% | 0.00% | – |
| Q3 2015 | $42,000 | -67.4% | 12,031 | -7.2% | 0.00% | -100.0% |
| Q2 2015 | $129,000 | -18.9% | 12,971 | +4.0% | 0.00% | 0.0% |
| Q1 2015 | $159,000 | -22.8% | 12,471 | -14.4% | 0.00% | -50.0% |
| Q4 2014 | $206,000 | +32.1% | 14,571 | +28.1% | 0.00% | 0.0% |
| Q3 2014 | $156,000 | -41.4% | 11,371 | -34.3% | 0.00% | -33.3% |
| Q2 2014 | $266,000 | +62.2% | 17,305 | +79.6% | 0.00% | +50.0% |
| Q1 2014 | $164,000 | 0.0% | 9,634 | -23.7% | 0.00% | -33.3% |
| Q4 2013 | $164,000 | +13.1% | 12,634 | -11.9% | 0.00% | 0.0% |
| Q3 2013 | $145,000 | +34.3% | 14,334 | -0.7% | 0.00% | 0.0% |
| Q2 2013 | $108,000 | – | 14,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |